DeepMed Research

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.nebraska.edu

Clinical Trials

Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer

Phase 2

Completed

Conditions: Stage IA Pancreatic Cancer
Stage IB Pancreatic Cancer
Pancreatic Adenocarcinoma
Stage I Pancreatic Cancer
Stage II Pancreatic Cancer
Stage IIB Pancreatic Cancer
Resectable Pancreatic Carcinoma
Stage IIA Pancreatic Cancer
Stage III Pancreatic Cancer

Interventions: Procedure: 4-Dimensional Computed Tomography
Drug: Fluorouracil
Drug: Gemcitabine Hydrochloride
Other: Laboratory Biomarker Analysis
Drug: Leucovorin Calcium
Drug: Nelfinavir Mesylate
Biological: Oregovomab
Radiation: Stereotactic Body Radiation Therapy
Procedure: Therapeutic Conventional Surgery

First Posted Date: 2013-10-10

Last Posted Date: 2023-10-10

Lead Sponsor: University of Nebraska

Target Recruit Count: 11

Registration Number: NCT01959672

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Treatment of Vitamin D Deficiency in Intestinal Rehabilitation Clinic Patients With a Portable Ultraviolet B Lamp

Not Applicable

Completed

Conditions: Vitamin D Deficiency
Short Bowel Syndrome

Interventions: Device: Ultraviolet B lamp

First Posted Date: 2013-08-29

Last Posted Date: 2023-10-04

Lead Sponsor: University of Nebraska

Target Recruit Count: 11

Registration Number: NCT01930539

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Cardiac Allograft Remodeling and Effects of Sirolimus

Phase 1

Terminated

Conditions: Cardiac Hypertrophy
Immunosuppression

Interventions: Procedure: Cardiac Biopsy C4D stain
Genetic: Genetic Mechanism of M-TOR
Radiation: Cardiac MRI
Procedure: Coronary angiography with IVUS
Other: Cardiopulmonary Exercise Test (CPET)
Other: Cardiac Allograft Remodeling
Drug: M-TOR Immunosuppression

First Posted Date: 2013-07-01

Last Posted Date: 2023-08-30

Lead Sponsor: University of Nebraska

Target Recruit Count: 42

Registration Number: NCT01889992

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Health Behavior-Related Outcomes With Diaphragmatic Breathing Retraining in Heart Failure Patients

Not Applicable

Withdrawn

Conditions: Chronic Heart Failure

Interventions: Behavioral: Diaphragmatic Breathing Retraining

First Posted Date: 2013-06-25

Last Posted Date: 2024-10-17

Lead Sponsor: University of Nebraska

Registration Number: NCT01886391

EFV Pharmacokinetics & Pharmacogenomics in Older HIV-infected Patients

Completed

Conditions: HIV Infection

Interventions: Drug: Efavirenz

First Posted Date: 2013-06-25

Last Posted Date: 2023-12-12

Lead Sponsor: University of Nebraska

Target Recruit Count: 30

Registration Number: NCT01886404

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Leukine (Sargramostim) for Parkinson's Disease

Phase 1

Completed

Conditions: Parkinson's Disease

Interventions: Drug: placebo
Drug: sargramostim

First Posted Date: 2013-06-20

Last Posted Date: 2023-10-06

Lead Sponsor: University of Nebraska

Target Recruit Count: 37

Registration Number: NCT01882010

Locations: 🇺🇸
Neurology Consultants of Nebraska PC, Omaha, Nebraska, United States
🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Comparison of Epidural and TAP Block in Abdominal Surgery

Completed

Conditions: Regional Anesthesia
Acute Pain
Surgery

Interventions: Drug: Epidural
Drug: TAP Block

First Posted Date: 2013-05-08

Last Posted Date: 2023-11-28

Lead Sponsor: University of Nebraska

Target Recruit Count: 72

Registration Number: NCT01848951

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer

Phase 1

Completed

Conditions: Ampulla of Vater Adenocarcinoma
Gallbladder Adenocarcinoma
Metastatic Pancreatic Adenocarcinoma
Pancreatic Adenocarcinoma
Stage III Ampulla of Vater Cancer
Stage III Intrahepatic Cholangiocarcinoma
Stage III Pancreatic Cancer
Stage IIIA Gallbladder Cancer
Stage IIIA Hilar Cholangiocarcinoma
Stage IIIB Gallbladder Cancer

Interventions: Drug: ADH-1
Drug: Cisplatin
Drug: Gemcitabine Hydrochloride
Other: Laboratory Biomarker Analysis

First Posted Date: 2013-04-05

Last Posted Date: 2023-12-28

Lead Sponsor: University of Nebraska

Target Recruit Count: 17

Registration Number: NCT01825603

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

The Effect of Exercise on Strength and Mobility and Corresponding CNS Plasticity in Multiple Sclerosis Patients

Not Applicable

Completed

Conditions: Multiple Sclerosis

Interventions: Other: specifically design 6 month resistance training program
Behavioral: 6 months weight resistance and balance program

First Posted Date: 2013-03-21

Last Posted Date: 2023-09-01

Lead Sponsor: University of Nebraska

Target Recruit Count: 6

Registration Number: NCT01816100

Locations: 🇺🇸
Unversity of Nebraska Medical Center, Omaha, Nebraska, United States

Lower Extremity Regional Anesthesia and Infrainguinal Bypass Grafting

Withdrawn

Conditions: Peripheral Vascular Disease

Interventions: Procedure: Single shot femoral and sciatic nerve block

First Posted Date: 2013-03-04

Last Posted Date: 2023-08-14

Lead Sponsor: University of Nebraska

Registration Number: NCT01803165

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy